Patient preferences and adherence to adjuvant GnRH analogs among premenopausal women with hormone receptor positive breast cancer-Reference-Cited by-同舟云学术

Patient preferences and adherence to adjuvant GnRH analogs among premenopausal women with hormone receptor positive breast cancer

Published:2021-09-08 Issue:2 Volume:190 Page:183-188
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Sukumar Jasmine S.,Quiroga Dionisia,Kassem Mahmoud,Grimm Michael,Shinde Namrata Vilas,Appiah Leslie,Palettas Marilly,Stephens Julie,Gatti-Mays Margaret E.,Pariser Ashley,Cherian Mathew,Stover Daniel G.,Williams Nicole,Van Deusen Jeffrey,Wesolowski Robert,Lustberg Maryam,Ramaswamy Bhuvaneswari,Sardesai Sagar^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s10549-021-06368-4.pdf

Reference27 articles.

1. Francis PA, Pagani O, Fleming GF, Walley BA, Colleoni M, Láng I, Gómez HL, Tondini C, Ciruelos E, Burstein HJ et al (2018) Tailoring adjuvant endocrine therapy for premenopausal breast cancer. N Engl J Med 379(2):122–137

2. Qiu L, Fu FM, Huang M, Lin YX, Chen YZ, Chen MY, Wang C (2016) Evaluating the survival benefit following ovarian function suppression in premenopausal patients with hormone receptor positive early breast cancer. Sci Rep 6:11

3. Lambertini M, Viglietti G, de Azambuja E (2019) Impact of ovarian function suppression in premenopausal women with estrogen receptor-positive early breast cancer. Curr Opin Oncol 31(1):43–51

4. Ferreira AR, Ribeiro J, Miranda A, Mayer A, Passos-Coelho JL, Brito M, Fernandes J, Gouveia J, Costa L, Vaz-Luis I (2019) effectiveness of adjuvant ovarian function suppression in premenopausal women with early breast cancer: a multicenter cohort study. Clin Breast Cancer 19(5):e654–e667

5. Francis PA, Regan MM, Fleming GF, Láng I, Ciruelos E, Bellet M, Bonnefoi HR, Climent MA, Da Prada GA, Burstein HJ et al (2015) Adjuvant ovarian suppression in premenopausal breast cancer. N Engl J Med 372(5):436–446

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Overview of Long-Acting GnRH Agonists in Premenopausal Breast Cancer Patients: Survivorship Challenges and Management;Current Oncology;2024-07-25

2. Knowledge and prevalence of common sexually transmitted infections among patients seeking care at selected health facilities in Southern Ghana;PLOS Global Public Health;2024-07-01

3. Different dosage forms of gonadotropin-releasing hormone agonist with endocrine therapy in premenopausal hormone receptor–positive breast cancer;JNCI: Journal of the National Cancer Institute;2024-06-04

4. The role of exercise in aromatase inhibitor‐induced arthralgia;PM&R;2024-05-23

5. Effectiveness of gonadotropin-releasing hormone agonists for ovarian function suppression in premenopausal patients with hormone receptor-positive breast cancer: a retrospective single-center real-world study;Breast Cancer Research and Treatment;2024-05-06